A comparison of estrogen replacement, pravastatin, and combined treatment for the management of hypercholesterolemia in postmenopausal women.
- 9 June 1997
- journal article
- clinical trial
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 157 (11) , 1186-1192
- https://doi.org/10.1001/archinte.1997.00440320068007
Abstract
To evaluate and compare the lipid-altering effects of conjugated estrogens and pravastatin, alone and in combination, in postmenopausal women with hypercholesterolemia.This publication has 10 references indexed in Scilit:
- Efficacy of sequential hormone replacement therapy in the treatment of hypercholesterolemia among postmenopausal womenJournal of Internal Medicine, 1995
- Major Issues Regarding Estrogen Replacement Therapy in Postmenopausal WomenJournal of Women's Health, 1994
- Hormonal Treatment of Postmenopausal WomenNew England Journal of Medicine, 1994
- Excess body weight. An under-recognized contributor to dyslipidemia in white American womenArchives of internal medicine (1960), 1994
- Post-menopausal hormone replacement therapy, coronary heart disease and plasma lipoproteinsCurrent Opinion in Lipidology, 1994
- Differential effects of estrogen on low-density lipoprotein subclasses in healthy postmenopausal womenMetabolism, 1993
- Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidencePreventive Medicine, 1991
- Management of Dyslipidemia in NIDDMDiabetes Care, 1990
- Sex, plasma lipoproteins, and atherosclerosis: Prevailing assumptions and outstanding questionsAmerican Heart Journal, 1987
- Summary estimates of cholesterol used to predict coronary heart disease.Circulation, 1983